{
  "company": {
    "name": "Glycomine",
    "website": "https://glycomine.com/",
    "record": "https://startuphistory.org/c/glycomine.com"
  },
  "status": null,
  "history_since": "2015-10-12T15:27:20.000Z",
  "baseline": {
    "snapshot_id": "ec9853e8a9bb9a41651febeb3fb3201bf8c7aa1000b560ccee227f4c70464853",
    "observed_at": "2015-10-12T15:27:20.000Z",
    "headline": "Developing nanomedicines for rare genetic disorders",
    "description": null,
    "evidence": "https://web.archive.org/web/20151012152720/http://glycomine.com/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [
            "FDA APPROVED"
          ],
          "funding": []
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:13:23.485Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2018-01-19T12:25:17.000Z",
      "variants": [
        {
          "headline": "Developing nanomedicines for rare genetic disorders",
          "subhead": null,
          "observed_at": "2015-10-12T15:27:20.000Z",
          "evidence": "https://web.archive.org/web/20151012152720/http://glycomine.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing replacement therapies for rare genetic disorders",
          "subhead": null,
          "observed_at": "2016-11-29T20:51:04.000Z",
          "evidence": "https://web.archive.org/web/20161129205104/http://glycomine.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing replacement therapies for rare genetic disorders",
          "subhead": null,
          "observed_at": "2018-01-19T12:25:17.000Z",
          "evidence": "https://web.archive.org/web/20180119122517/http://glycomine.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Developing replacement therapies for rare genetic disorders",
      "subhead": null,
      "from": "2015-10-12T15:27:20.000Z",
      "to": "2018-01-19T12:25:17.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20180119122517/http://glycomine.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2015-10-12T15:27:20.000Z",
          "to": "2018-01-19T12:25:17.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2020-08-14T17:17:59.000Z",
      "variants": [
        {
          "headline": "Developing therapies for critical unmet orphan diseases of glycosylation",
          "subhead": null,
          "observed_at": "2019-01-07T13:36:17.000Z",
          "evidence": "https://web.archive.org/web/20190107133617/https://glycomine.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing therapies for critical unmet orphan diseases of glycosylation",
          "subhead": null,
          "observed_at": "2020-08-14T17:17:59.000Z",
          "evidence": "https://web.archive.org/web/20200814171759/https://glycomine.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Developing therapies for critical unmet orphan diseases of glycosylation",
      "subhead": null,
      "from": "2019-01-07T13:36:17.000Z",
      "to": "2020-08-14T17:17:59.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20200814171759/https://glycomine.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2019-01-07T13:36:17.000Z",
          "to": "2020-08-14T17:17:59.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:13:23.485Z",
      "variants": [
        {
          "headline": "The Missing Piece For Rare Genetic Diseases",
          "subhead": "We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.",
          "observed_at": "2022-01-24T22:35:55.000Z",
          "evidence": "https://web.archive.org/web/20220124223555/https://www.glycomine.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The Missing Piece For Rare Genetic Diseases",
          "subhead": "We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.",
          "observed_at": "2023-01-09T14:03:16.000Z",
          "evidence": "https://web.archive.org/web/20230109140316/https://www.glycomine.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The Missing Piece For Rare Genetic Diseases",
          "subhead": "We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.",
          "observed_at": "2024-01-04T14:01:36.000Z",
          "evidence": "https://web.archive.org/web/20240104140136/https://www.glycomine.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The Missing Piece For Rare Genetic Diseases",
          "subhead": "We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.",
          "observed_at": "2025-07-19T14:59:44.000Z",
          "evidence": "https://web.archive.org/web/20250719145944/https://www.glycomine.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The Missing Piece For Rare Genetic Diseases",
          "subhead": "We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.",
          "observed_at": "2026-07-09T22:19:06.000Z",
          "evidence": "https://web.archive.org/web/20260709221906/https://www.glycomine.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The Missing Piece For Rare Genetic Diseases",
          "subhead": "We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.",
          "observed_at": "2026-11-06T17:13:23.485Z",
          "evidence": "https://www.glycomine.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "The Missing Piece For Rare Genetic Diseases",
      "subhead": "We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.",
      "from": "2022-01-24T22:35:55.000Z",
      "to": "2026-11-06T17:13:23.485Z",
      "captures": 6,
      "evidence": "https://www.glycomine.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2022-01-24T22:35:55.000Z",
          "to": "2026-11-06T17:13:23.485Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-ec9853e8a9bb9a41651febeb3fb3201bf8c7aa1000b560ccee227f4c70464853:ba94501fde8467fab1d4cd84930bd78f71fa977e899072229a77e4bbec0495ce:funding:0dd2be6c8894e954",
      "before_evidence": "https://web.archive.org/web/20151012152720/http://glycomine.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “company’s fundraising efforts for Seed and Series A raising nearly $13M to-date.”.",
      "between": {
        "from": "2015-10-12T15:27:20.000Z",
        "to": "2016-11-29T20:51:04.000Z"
      },
      "evidence": "https://web.archive.org/web/20161129205104/http://glycomine.com:80/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 2,
      "id": "page-ba94501fde8467fab1d4cd84930bd78f71fa977e899072229a77e4bbec0495ce:e8c22a78031a54dc3b3bf2ca4096caafb004a6b0d36d6c1585985d562f631faa:funding:4e4b3d1470a28687",
      "before_evidence": "https://web.archive.org/web/20161129205104/http://glycomine.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “Announces $12 Million Series A Financing to Advance a New Generation of Replacement Therapies for Rare Diseases Read the press release Re…”.",
      "between": {
        "from": "2016-11-29T20:51:04.000Z",
        "to": "2018-01-19T12:25:17.000Z"
      },
      "evidence": "https://web.archive.org/web/20180119122517/http://glycomine.com:80/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 3,
      "id": "page-e8c22a78031a54dc3b3bf2ca4096caafb004a6b0d36d6c1585985d562f631faa:f5bf6d88b4fd7c90d544d662375890546fb816f7d4cfebd2661e82b8173e84af:headline:39a63ba8b70bdbb4",
      "before_evidence": "https://web.archive.org/web/20180119122517/http://glycomine.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Developing replacement therapies for rare genetic disorders” to “Developing therapies for critical unmet orphan diseases of glycosylation”.",
      "between": {
        "from": "2018-01-19T12:25:17.000Z",
        "to": "2019-01-07T13:36:17.000Z"
      },
      "evidence": "https://web.archive.org/web/20190107133617/https://glycomine.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 4,
      "id": "page-f5bf6d88b4fd7c90d544d662375890546fb816f7d4cfebd2661e82b8173e84af:d01edf7898ee388259cd62514282431787e6c94abc4677c035ff55f22239e1f7:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20190107133617/https://glycomine.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2019-01-07T13:36:17.000Z",
        "to": "2020-08-14T17:17:59.000Z"
      },
      "evidence": "https://web.archive.org/web/20200814171759/https://glycomine.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 5,
      "id": "page-d01edf7898ee388259cd62514282431787e6c94abc4677c035ff55f22239e1f7:50e5e4f7e4924552a81ea58996464b04912ec152f14ae002d5ea64b78bea82b3:headline:c588726e44251b1b",
      "before_evidence": "https://web.archive.org/web/20200814171759/https://glycomine.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Developing therapies for critical unmet orphan diseases of glycosylation” to “The Missing Piece For Rare Genetic Diseases”.",
      "between": {
        "from": "2020-08-14T17:17:59.000Z",
        "to": "2022-01-24T22:35:55.000Z"
      },
      "evidence": "https://web.archive.org/web/20220124223555/https://www.glycomine.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Glycomine” company record, https://startuphistory.org/c/glycomine.com"
}